BIBF1120, an investigational triple angiokinase inhibitor, in combination with inhibitors of mTOR signaling shows potent antitumor activity in preclinical models of sarcoma Meeting Abstract


Authors: Patwardhan, P. P.; Musi, E.; Ivy, K. S.; Giovino, N.; Schwartz, G. K.
Abstract Title: BIBF1120, an investigational triple angiokinase inhibitor, in combination with inhibitors of mTOR signaling shows potent antitumor activity in preclinical models of sarcoma
Meeting Title: 105th Annual Meeting of the American Association for Cancer Research (AACR)
Journal Title: Cancer Research
Volume: 74
Issue: 19 Suppl.
Meeting Dates: 2014 Apr 5-9
Meeting Location: San Diego, CA
ISSN: 0008-5472
Publisher: American Association for Cancer Research  
Date Published: 2014-10-01
Language: English
ACCESSION: WOS:000349910202499
DOI: 10.1158/1538-7445.am2014-4526
PROVIDER: wos
Notes: Meeting Abstract: 4526 -- 105th Annual Meeting of the American-Association-for-Cancer-Research (AACR) -- APR 05-09, 2014 -- San Diego, CA -- S -- Source: Wos
Altmetric Score
MSK Authors
  1. Gary Schwartz
    366 Schwartz
  2. Elgilda Musi
    8 Musi
  3. Kathryn Stevens Ivy
    2 Ivy
Related MSK Work